2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children
Authors
Keywords
Pediatrics, Antiemetics, Chemotherapy-induced vomiting, Chemotherapy-induced nausea, Supportive care
Journal
SUPPORTIVE CARE IN CANCER
Volume 25, Issue 1, Pages 323-331
Publisher
Springer Nature
Online
2016-08-26
DOI
10.1007/s00520-016-3384-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study
- (2016) Gábor Kovács et al. LANCET ONCOLOGY
- Feasibility of psychoeducational interventions in managing chemotherapy-associated nausea and vomiting (CANV) in pediatric oncology patients
- (2015) Carmen W.H. Chan et al. European Journal of Oncology Nursing
- Rolapitant for the treatment of chemotherapy-induced nausea and vomiting
- (2015) Rudolph M Navari Expert Review of Anticancer Therapy
- Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial
- (2015) Hyoung Jin Kang et al. LANCET ONCOLOGY
- Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial
- (2015) Sameer Bakhshi et al. SUPPORTIVE CARE IN CANCER
- Olanzapine for treatment and prevention of acute chemotherapy-induced vomiting in children: A retrospective, multi-center review
- (2014) Jacqueline Flank et al. PEDIATRIC BLOOD & CANCER
- Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients
- (2013) L. Lee Dupuis et al. PEDIATRIC BLOOD & CANCER
- Association Between Corticosteroids and Infection, Sepsis, and Infectious Death in Pediatric Acute Myeloid Leukemia (AML): Results From the Canadian Infections in AML Research Group
- (2012) David Dix et al. CLINICAL INFECTIOUS DISEASES
- Reduction in Nausea and Vomiting in Children Undergoing Cancer Chemotherapy by Either Appropriate or Sham Auricular Acupuncture Points with Standard Care
- (2012) Chao Hsing Yeh et al. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
- Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients
- (2011) L. Lee Dupuis et al. PEDIATRIC BLOOD & CANCER
- Development and Validation of a Pictorial Nausea Rating Scale for Children
- (2011) A. L. Baxter et al. PEDIATRICS
- Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
- (2010) F. Roila et al. ANNALS OF ONCOLOGY
- Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy
- (2010) Anu Kochanujan Pillai et al. PEDIATRIC BLOOD & CANCER
- Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009
- (2010) Karin Jordan et al. SUPPORTIVE CARE IN CANCER
- Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: Guideline update and results of the Perugia consensus conference
- (2010) Fausto Roila et al. SUPPORTIVE CARE IN CANCER
- Palonosetron Hydrochloride Is an Effective and Safe Option to Prevent Chemotherapy-induced Nausea and Vomiting in Children
- (2008) Ana Carolina Sepúlveda-Vildósola et al. ARCHIVES OF MEDICAL RESEARCH
- Stability of an extemporaneous oral liquid aprepitant formulation
- (2008) L. Lee Dupuis et al. SUPPORTIVE CARE IN CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started